PD318088

CAS No. 391210-00-7

PD318088( PD 318088 | PD-318088 )

Catalog No. M14344 CAS No. 391210-00-7

PD318088 is a potent, non-ATP competitive, allosteric MEK1/2 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 75 In Stock
5MG 120 In Stock
10MG 227 In Stock
25MG 426 In Stock
50MG 626 In Stock
100MG 888 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PD318088
  • Note
    Research use only, not for human use.
  • Brief Description
    PD318088 is a potent, non-ATP competitive, allosteric MEK1/2 inhibitor.
  • Description
    PD318088 is a potent, non-ATP competitive, allosteric MEK1/2 inhibitor, binds simultaneously with ATP in a region of the MEK1 active site that is adjacent to the ATP-binding site.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PD 318088 | PD-318088
  • Pathway
    MAPK/ERK Signaling
  • Target
    MEK
  • Recptor
    MEK1|MEK2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    391210-00-7
  • Formula Weight
    561.0891
  • Molecular Formula
    C16H13BrF3IN2O4
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(NOCC(O)CO)C1=CC(Br)=C(F)C(F)=C1NC2=CC=C(I)C=C2F
  • Chemical Name
    Benzamide, 5-bromo-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Han S, et al. Bioorg Med Chem Lett. 2005 Dec 15;15(24):5467-73. 2. Zhang Y, et al. Mol Med Rep. 2014 Jan;9(1):83-90. 3. Ohren JF, et al. Nat Struct Mol Biol. 2004 Dec;11(12):1192-7.
molnova catalog
related products
  • Tpl2-IN-2p

    A potent, selective, reversible and ATP-competitive inhibitor of Tpl2 kinase with IC50 of 50 nM.

  • Refametinib R enanti...

    The R enantiomer of Refametinib, a potent, non–ATP-competitive, highly selective, allosteric inhibitor.

  • AKS1-IN-19

    A novel potent, selective and orally active ASK1 (MAP3K5) inhibitor with pIC50 of 8.3.